Related Articles
TP53 upregulates α‑smooth muscle actin expression in tamoxifen‑resistant breast cancer cells
MEK activity controls IL-8 expression in tamoxifen-resistant MCF-7 breast cancer cells
Differential effect of EGFR inhibitors on tamoxifen-resistant breast cancer cells
Inhibition of tumor growth and angiogenesis of tamoxifen‑resistant breast cancer cells by ruxolitinib, a selective JAK2 inhibitor
TPA-induced p21 expression augments G2/M arrest through a p53-independent mechanism in human breast cancer cells